Discover 1,423 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,423
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
for
Prostate Cancer, Malignant Neoplasm of Prostate,
Location: Cleveland OH, New York NY, Madison WI
Sponsor: Case Comprehensive Cancer Center
Sex: Male
Age: 18+
Code: NCT06150417
Phase2, Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Cleveland OH, Columbus OH, Detroit MI, Louisville KY,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18 - 70
Code: NCT03217006
Recruiting
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
for
Stress Urinary Incontinence (SUI)
Location: Cleveland OH, Durham NC, Charlotte NC,
Sponsor: UroMems SAS
Sex: Male
Age: 22+
Code: NCT06968741
Recruiting
TSC Biosample Repository and Natural History Database
for
Tuberous Sclerosis, Lymphangioleiomyomatosis
Location: Cleveland OH, Cincinnati OH, Rochester NY, Fairfax VA,
Sponsor: National Tuberous Sclerosis Association
Sex: All
Age: 0+
Code: NCT05676099
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
for
Advanced Solid Tumors, HER2 Mutation
Location: Cleveland OH, Toronto, Nashville TN, Boston MA,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06760819
Phase2, Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for
Primary Immune Thrombocytopenia (ITP)
Location: Cleveland OH, Columbus OH, Detroit MI,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06544499
Phase3, Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)